Erratum: Affiliations Correction

정회윤,유영춘,김인보,성낙윤,최옥병,최보화,김종배,Jung, Hoe-Yune,Yoo, Yung Choon,Kim, Inbo,Sung, Nak Yun,Choi, Ok-Byung,Choi, Bo-Hwa,Kim, Jong-Bae The Korean Society of Food Science and Nutrition 2015 한국식품영양과학회지 Vol.44 No.6

한국산 겨우살이 추출물(KME)의 2형 당뇨 억제 및 근육세포 미토콘드리아 생성 증가 효과

정회윤(Hoe-Yune Jung),유영춘(Yung Choon Yoo),김인보(Inbo Kim),성낙윤(Nak Yun Sung),최옥병(Ok-Byung Choi),최보화(Bo-Hwa Choi),김종배(Jong-Bae Kim) 한국식품영양과학회 2015 한국식품영양과학회지 Vol.44 No.3

본 연구에서는 C57BL/6J ob/ob 마우스를 이용하여 한국산 겨우살이 냉수 추출물(KME)의 항당뇨 활성을 조사하였다. 50 혹은 100 mg/kg의 KME를 1일 1회씩 경구투여 한 결과 KME 투여 개시 5일 후부터 ob/ob 마우스의 혈당이 유의하게 억제되었으며, 10일 후부터 안정된 억제 효과를 나타내고 대조군에 비해 20% 이상의 혈당강하 효과를 나타내었다. 경구 당부하 실험(OGTT)에서는 KME 경구투여 마우스에서 유효한 당부하 억제 활성이 관찰되었다. 또한 KME 경구투여는 ob/ob 당뇨 마우스의 혈액 내 총 콜레스테롤과 중성지질의 농도를 억제하는 것으로 나타났다. 한편 C2C12 근육세포를 이용한 in vitro 실험에서 KME를 처리함으로써 glucose uptake가 현저히 증가하였다. 한편 매우 흥미롭게도 KME를 처리한 C2C12 근육세포에 있어서 미토콘드리아 생성과 산화대사 조절물질인 peroxisome proliferatoractivated receptor gamma coactivator 1-α(PGC-1α)를 비롯하여 glucose transporter type 4(GLUT4), estrogen-related receptor-α(ERR-α), nuclear respiratory factor-1(NRF-1) 그리고 mitochondrial transcription factor A(TmfA)와 같은 PGC-1α 관련 유전자들의 발현이 증가하는 것으로 확인되었다. 이 결과는 KME가 2형 당뇨에 대한 치료물질로서의 작용을 지니며 이러한 KME의 항당뇨 활성은 미토콘드리아 생성의 조절과 관련 있는 것으로 추정된다. In this study, the anti-diabetic activity of a cold water extract of Korean mistletoe (KME) was investigated in C57BL/6J Lep ob (ob/ob) mice. Oral administration of KME (50 or 100 mg/kg/d) significantly inhibited the level of blood glucose of ob/ob mice after 5 days from the beginning of KME treatment. And the anti-diabetic effect of KME was stabilized 10 days after oral administration, showing a substantial reduction of blood glucose levels by more than 20% as compared with control mice. The results of oral glucose tolerance test (OGTT) revealed that oral administration of KME gave rise to a remarkable improvement in overall glucose response. Oral administration of KME in ob/ob diabetic mice also significantly reduced blood total cholesterol (TCHO) and triglyceride (TG) levels compared with the diabetic control mice. Moreover, in an in vitro experiment using C2C12 myotubes, treatment of KME prominently increased glucose uptake. Interestingly, KME significantly increased the expression of peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α), a head regulator of mitochondrial biogenesis and oxidative metabolism, and PGC-1α-associated genes such as glucose transporter type 4 (GLUT4), estrogen-related receptor-α (ERR-α), nuclear respiratory factor-1 (NRF-1), and mitochondrial transcription factor A (TmfA) in C2C12 cells. These results suggest that KME has potential as a novel therapeutic agent for diabetes, and its anti-diabetic activity may be related to the regulation of mitochondrial biogenesis.

여주(Momordica charantia) 추출물이 생쥐의 지구력 운동수행능력 향상 효과에 미치는 영향

김인보,박춘호,정회윤,정주성,홍환웅,김종배,Kim, Inbo,Park, Choon-Ho,Jung, Hoe-Yune,Jeong, Juseong,Hong, Hwan-Ung,Kim, Jong Bae 한국식품영양학회 2016 韓國食品營養學會誌 Vol.29 No.4

Bitter melon (Momordica charantia) is used in traditional herbal medicine in many Asian countries for the treatment of several diseases such as diabetes, eczema, night blindness, psoriasis, and rheumatism. Especially, most reports concerning the biological activities of bitter melon have focused on its effects on diabetes and hyperglycemia. Also, bitter melon is regarded as a longevity food, suggesting that it has several beneficial effects on anti-aging and the maintenance of a healthy state. Thus, we investigated whether bitter melon could increase the capacity of exercise in this study. Interestingly, bitter melon fruit extract activated AMP-activated protein kinase (AMPK), which is important for regulating glucose homeostasis, mitochondrial content and exercise capacity. In addition, bitter melon extract increased the expression of enzymes involved in fatty acid oxidation such as mitochondrial uncoupling protein 3 (UCP3), carnitine palmitoyl transferase 1b (CPT1b), and pyruvate dehydrogenase lipoamide kinase isozyme 4 (PDK4). Moreover, exercise tolerance was much more enhanced in bitter melon treated animals compared to the non-treated control group. These results suggest that bitter melon is a promising candidate for the development of functional foods beneficial for physical strength and the enhancement of exercise capacity.

가시오가피를 이용한 기능성 건강음료의 제조

성미선(Mi-Sun Sung),정회윤(Hoe-Yune Jung),최준혁(Jun-Hyeok, Choi),이성철(Sung-Cheol Lee),최보화(Bo-Hwa Choi),박성선(Sung Sun Park) 한국생명과학회 2014 생명과학회지 Vol.24 No.9

본 연구에서는 가시오가피 줄기를 이용하여 농축액을 제조한 후 운동수행능력 증진 효과를 확인하고, 관능검사를 통해 가시오가피의 유용한 기능적인 특성을 살린 기호성 있는 건강 음료를 제조한 후 그 품질 특성을 조사하여 가공식품 및 식품소재로서 가시오가피의 활용도를 높이기 위한 기초 연구 자료로 제시하고자 하였다. 본 실험에서 사용한 건가시오가피 줄기의 일반성분 분석 결과 수분함량 6.50±0.12%, 조단백질 5.89±0.16%, 조지방 1.18±0.11%, 조회분 3.03±0.40%로 나타났다. 건가시오가피 줄기 추출물을 이용하여 제조한 가시오가피 농축액의 DPPH 라디칼 소거능은 증류수로 희석한 10% 농축액에서 87.42±1.63%로 나타나 positive control인 butylated hydroxy anisole (BHA) 1%의 DPPH 라디칼 소거활성 88.65±2.42%와 비슷한 수준으로 높은 활성을 보였으며, 최대운동수행능력을 측정한 결과 가시오가피 농축액을 섭취한 생쥐에서 대조군 생쥐에 비해 농도 의존적으로 운동수행 거리와 시간이 증가하는 것으로 확인되었다. 그리고 관능검사를 통해 선호도가 가장 높은 가시오가피 음료를 제조하여 그 특성을 확인한 결과 당도는 14.9 °Brix, pH는 4.51, 색도는 L값(명도) -62.70, a값(적색도) 3.67, b값(황색도) -6.12로 확인되었다. 따라서 본 연구의 결과는 가시오가피 농축액을 이용한 기호도가 증진된 기능성 음료로의 개발이 가능할 것으로 생각된다. This study was carried out to develop a functional healthy drink using 60% ethanol of dried Acanthopanax senticosus stem extract (ASE). The preparation, physical activity, anti-oxidant activity, and sensory properties of ASE were investigated. The moisture, crude protein, crude lipid, and ash contents of dried ASE were 6.50±0.12%, 5.89±0.16, 1.18±0.11, and 3.03±0.40, respectively. The 1,1-Diphenyl-2- picrylhydrazyl (DPPH) radical scavenging activity was 87.42±1.63% at 1/10 folds diluted ASE. In total, 40 male ICR mice were divided into five groups including the control (PBS), positive control (Red ginseng 200 mg/kg/day), and ASE-treated groups at doses of 35, 70, and 140 mg/kg/day for five weeks, respectively. ASE was administrated orally one time per day for five weeks before treadmill exercises, and normal and positive controls were fed PBS and red ginseng extract. In the treadmill test, ASE-treated mice (140 mg/kg/day) could run 1.4 times longer than the control mice. Healthy drinks were prepared with the addition of ASE at levels of 0.97% or 0.49% (A, B, and C type). Among the healthy drinks, the B type (ASE, 0.97%) was revealed to have the highest level of taste and overall acceptability through a sensory evaluation. The brix and pH of the ASE health drink (B type) were 14.9 and 4.51, respectively. These results indicated that the dried stem of Acanthopanax senticosus could be used as a functional material in the health drink industry.

한국산 겨우살이 유산균 발효 추출물의 독성 및 면역증강 효과

윤택준(Taek Joon Yoon),양웅석(Woong Suk Yang),박성민(Sung Min Park),정회윤(Hoe Yune Jung),이안나(An Na Lee),정진혁(Jin Hyuk Jung),강태봉(Tae Bong Kang),유영춘(Yung Choon Yoo),김종배(Jong Bae Kim) 한국식품과학회 2009 한국식품과학회지 Vol.41 No.5

Lactobacillus casei KCTC 2180 및 Lact. plantarum KCTC 3103으로 발효된 한국산 겨우살이 추출물인 FKM-110의 렉틴 성분의 함량 변화, 독성 및 면역증강 효과를 검토하여 다음과 같은 결과를 얻었다. 두 가지 유산균을 이용하여 KM-110을 1-3일간 발효시킨 결과, 렉틴 성분은 발효 전에 비하여 53-71% 정도의 함량을 나타냄으로서 감소되는 경향을 보였다. 마우스에 대한 시료의 독성시험을 위하여 각 시료를 피하 주사하고 LDsub{50} 값을 측정한 결과, KM-110은 50-100 mg/kg인 반면 유산균으로 발효된 겨우살이 추출물인 FKM-110은 150-200 mg/kg인 결과를 보임으로 발효에 의하여 in vivo 독성효과는 감소하는 경향을 보였다. 각 시료를 macrphage에 직접 자극하여 염증성 cytokine인 IL-1β 및 TNF-α의 생산능력을 조사한 결과, FKM-110이 KM-110에 비하여 낮은 cytokine의 생산양식을 나타냈다. 그러나 FKM-110의 항원 KLH에 대한 면역증가 효과를 항체 생산능으로 조사한 결과, KM-110과 차이 없이 항원 단독 투여군에 비하여 높은 역가의 항체가 생산되었다. 따라서 겨우살이 추출물을 유산균으로 발효시킨 결과, in vivo 독성은 감소하였으나 면역증강 활성은 KM-110과 동일하게 유지되는 결과를 얻었다. 따라서 겨우살이의 면역증강 활성에 관여하는 성분으로 렉틴 이외에 물질이 관여할 수 있음을 강하게 시사하였다. In this study, Korean mistletoe extract (KM-110) was fermented with two strains of Lactobacillus (FKM-110) and then toxicity, lectin content, and immune activities were investigated. The lectin content of FKM-110 was about 53- 71% lower than that of KM-110. When mice were subcutaneously administered with KM-110 and FKM-110, the LDsub{50} obtained for KM-110 treatment was 50-100 mg/kg as compared to 150-200 mg/mL for FKM-110. Each preparation stimulated macrophages directly and enhanced productivity of inflammatory cytokines such as TNF-α and IL-1β. FKM-110 treatment resulted in lower cytokine production compared to KM-110. When mice were immunized with Keyhol limpet hemocyanin (KLH) antigen along with KM-110 or FKM-110 administration, higher antibody titers to KLH were observed in the KM-110 or FKM-110 groups compared to mice immunized with KLH alone, thereby showing no difference between KM-110 and FKM-110. Therefore, fermentation of Korean mistletoe extract with these Lactobacillus strains decreased toxicity in vivo while the enhancement of immune activity by KM-110 and FKM-110 was similar. These data suggest that KM-110 fermentation tended to decrease lectin content and in vivo toxicity. In addition, other components in the fermented mistletoe extract appear to stimulate immuno-adjuvant activity instead of lectin.